Composition
- Active ingredients
- DASABUVIR SODIUM EQ 200MG BASE; OMBITASVIR 8.33MG; PARITAPREVIR 50MG; RITONAVIR 33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA208624.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Viekira XR
- Active substance
- dasabuvir sodium
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Abbvie
- Status
- Discontinued
- FDA approval
- 22 Jul 2016
- Application
- NDA208624-001